Search research articles
Contact Us
Filters
Showing results (1-10 of 66) with videos related to
Page
of 7
Sort By:
Journal of Neuroendocrinology
|
May 9, 2008
Endogenous cannabinoids: structure and metabolism
T Bisogno
Expert Review of Clinical Pharmacology
|
July 5, 2016
The bright side of psychoactive substances: cannabinoid-based drugs in motor diseases
R Coccurello, T Bisogno
International Journal of Obesity (2005)
|
March 30, 2006
Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake
I Matias, T Bisogno, V Di Marzo
Current Pharmaceutical Design
|
July 21, 2000
Endocannabinoids: new targets for drug development
Di Marzo, T Bisogno, L De Petrocellis
Handbook of Experimental Pharmacology
|
April 7, 2006
The biosynthesis, fate and pharmacological properties of endocannabinoids
V Di Marzo, L De Petrocellis, T Bisogno
Expert Opinion on Therapeutic Targets
|
July 5, 2005
Endocannabinoids Part I: molecular basis of endocannabinoid formation, action and inactivation and development of selective inhibitors
V Di Marzo, L De Petrocellis, T Bisogno
Trends in Pharmacological Sciences
|
June 30, 2001
Anandamide: some like it hot
V Di Marzo, T Bisogno, L De Petrocellis
European Journal of Biochemistry
|
August 10, 2000
Comparative biology of the endocannabinoid system possible role in the immune response
M Salzet, C Breton, T Bisogno, et al.
Lipids
|
July 27, 1999
Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments
V Di Marzo, L De Petrocellis, T Bisogno, et al.
Journal of Neurochemistry
|
April 27, 1999
Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin
T Bisogno, D Melck, L De Petrocellis, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 66) with videos related to
Sort By:
Page
of 7
Journal of Neuroendocrinology
|
May 9, 2008
Endogenous cannabinoids: structure and metabolism
T Bisogno
Expert Review of Clinical Pharmacology
|
July 5, 2016
The bright side of psychoactive substances: cannabinoid-based drugs in motor diseases
R Coccurello, T Bisogno
International Journal of Obesity (2005)
|
March 30, 2006
Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake
I Matias, T Bisogno, V Di Marzo
Current Pharmaceutical Design
|
July 21, 2000
Endocannabinoids: new targets for drug development
Di Marzo, T Bisogno, L De Petrocellis
Handbook of Experimental Pharmacology
|
April 7, 2006
The biosynthesis, fate and pharmacological properties of endocannabinoids
V Di Marzo, L De Petrocellis, T Bisogno
Expert Opinion on Therapeutic Targets
|
July 5, 2005
Endocannabinoids Part I: molecular basis of endocannabinoid formation, action and inactivation and development of selective inhibitors
V Di Marzo, L De Petrocellis, T Bisogno
Trends in Pharmacological Sciences
|
June 30, 2001
Anandamide: some like it hot
V Di Marzo, T Bisogno, L De Petrocellis
European Journal of Biochemistry
|
August 10, 2000
Comparative biology of the endocannabinoid system possible role in the immune response
M Salzet, C Breton, T Bisogno, et al.
Lipids
|
July 27, 1999
Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments
V Di Marzo, L De Petrocellis, T Bisogno, et al.
Journal of Neurochemistry
|
April 27, 1999
Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin
T Bisogno, D Melck, L De Petrocellis, et al.
Page
of 7